Around the Practice

Multidisciplinary Management of HER2+ Breast Cancer

December 22nd 2021

Various healthcare professionals join to discuss the management of a patient diagnosed with HER2-positive breast cancer and consider how to best approach the patient with newer treatment strategies through her continuum of care.

Improving Outcomes in Newly Diagnosed Multiple Myeloma

December 21st 2021

Recommendations for introducing novel therapies into earlier lines of therapy for patients with transplant-eligible and transplant-ineligible multiple myeloma.

Management of Advanced Urothelial Carcinoma

December 10th 2021

Expert panelists follow a patient case to discuss locally advanced and metastatic urothelial carcinoma with a focus on frontline and maintenance therapy.

Around the Practice: Updates in Treating HER2+ Breast Cancer

November 30th 2021

A panel of experts discuss recent data results and updates happening within the HER2+ breast cancer treatment landscape.

Around The Practice: The Shifting Treatment Paradigm for Advanced Renal Cell Carcinoma

November 19th 2021

A panel of experts reflect on how to treat patients with advanced renal cell carcinoma by reviewing clinical trial data and discussing patient cases.

Around the Practice: Improving Outcomes in Advanced Prostate Cancer

November 18th 2021

Experts in prostate cancer discuss recent advances in the treatment of patients with metastatic castration-naive and metastatic castration-resistant prostate cancer and strategies for optimizing therapy.

The Evolving HER2+ Metastatic Breast Cancer Treatment Landscape

November 16th 2021

A panel of experts review data from recent conferences and discuss core challenges in the treatment of patients with HER2+ metastatic breast cancer.

Advances in the Treatment of Myelofibrosis

November 11th 2021

A panel of experts discusses current strategies used to stratify risk in patients with myelofibrosis and their preferences for sequencing therapy.

Updates in the Treatment of Chronic GVHD

October 29th 2021

Recommendations for treating patients with steroid-refractory chronic GVHD based on evidence demonstrated by the REACH3 trial.

Around the Practice: Improving Outcomes in Newly Diagnosed Multiple Myeloma

October 22nd 2021

Shared insight on strategies for optimizing frontline therapy for patients with newly diagnosed multiple myeloma, including those with high-risk disease.